In our lifetime, we could see AVM treatment move from surgery to outpatient embolization to taking a pill — but only if we can continue to advocate with scientists, doctors, the government, and pharmaceutical companies to make HHT a priority!

Cure HHT is the only organization in the world with the perseverance and the experience to integrate and drive vital progress across patient, medical, and scientific communities. Despite our small staff and modest budget, we have demonstrated a remarkable track record of success in all three of these arenas.

Cure HHT is at the epicenter of the national and global effort to advocate for patients and families, raise awareness of HHT, catalyze and sponsor critical research, create lasting collaborations, and advance treatments. As such, you can be sure that your investment in Cure HHT will go to the highest-return initiatives that can improve life of HHT patients today and in future generations.